SERUM NEURO-INJURY AND REDOX MARKERS IN DOGS WITH SUSPECTED DISTEMPER
DOI:
https://doi.org/10.26873/SVR-2273-2026Keywords:
anti-MOG, biomarkers, CDV, central nervous system damage, GFAP, NFL, oxidative stressAbstract
This study aimed to investigate central nervous system damage and oxidative stress in dogs brought to clinics and hospitals in Ankara, Türkiye with suspected distemper using the same sample. 19 dogs confirmed suspected positive Canine Distemper Virus (CDV+) with lateral flow immunochromatographic rapid test kits formed the ‘CDV+’ group, while 23 clinically healthy dogs with negative test results formed the ‘control’ group. The goal is to identify practical, serum-based markers that can be used for early diagnosis, prognosis determination, and monitoring treatment response in distemper. Glial fibrillary acidic protein (GFAP) levels were significantly higher in the CDV+ group compared to the control group (p = 0.011; False Discovery Rate (FDR-p) = 0.025), whereas Total oxidant status (TOS) and oxidative stress index (OSI) were unexpectedly low (FDR-p = 0.011 for both). No statistical differences were found in neurofilament light chain (NFL), myelin oligodendrocyte glycoprotein antibody (Anti-MOG), total antioxidant status (TAS), and malondialdehyde (MDA). In receiver operating characteristic (ROC) analysis, the area under the curve (AUC) for GFAP was 0.73, while TOS and OSI (interpreted inversely as indicating low-value disease) yielded AUC values of 0.78 and 0.79, respectively. At the best thresholds, GFAP ≥ 460 ng/L yielded 68% sensitivity and 74% specificity, while TOS ≤ 333 µmol/L and OSI ≤ 12 au thresholds yielded 91% specificity. The multiple logistic model (AUC = 0.86) increased sensitivity and specificity to 84% and 83%, respectively; however, only GFAP was a significant independent predictor (Odds Ratio (OR) ≈ 4.1; p = 0.048). In conclusion, serum GFAP appears to reflect central nervous system (CNS) involvement in dogs infected with distemper, and the combination of GFAP with low TOS and OSI values may enhance diagnostic specificity. These findings indicate that GFAP-based, oxidative marker-inclusive multi-biomarker panels could hold potential for supporting the early diagnosis and prognosis monitoring of canine distemper, although further validation in larger and longitudinal studies is warranted.
References
Martella V, Elia G, Buonavoglia C. Canine distemper virus. Vet Clin North Am Small Anim Pract 2008; 38(4): 787–97.
Rivera-Martínez A, Rodríguez-Alarcón CA, Adame-Gallegos JR, Laredo-Tiscareño SV, de Luna-Santillana EDJ, Hernández-Triana LM, Garza-Hernández JA. Canine Distemper Virus: Origins, Mutations, Diagnosis, and Epidemiology in Mexico. Life 2024; 14(8): 1002.
Carvalho OV, Botelho CV, Ferreira CGT, Scherer PO, Soares-Martins JAP, Almeida MR, Silva Júnior A. Immunopathogenic and neurological mecha-nisms of canine distemper virus. Adv Virol 2012; 2012: 163860.
Vandevelde M, Zurbriggen A. Demyelination in canine distemper virus infection: a review. Acta Neuropathol 2005; 109: 56–68.
Gaetani L, Paoletti FP, Bellomo G, Mancini A, Simoni S, Di Filippo M, Par-netti L. CSF and blood biomarkers in neuroinflammatory and neurodegene-rative diseases: implications for treatment. Trends Pharmacol Sci 2020; 41(12): 1023–37.
Miyake H, Inoue A, Tanaka M, Matsuki N. Serum glial fibrillary acidic protein as a specific marker for necrotizing meningoencephalitis in Pug dogs. J Vet Med Sci 2013; 75(11): 1543–5.
Sung J, Chae Y, Yun T, Koo Y, Lee D, Kim H, et al. Use of neurofilament light chain to identify structural brain diseases in dogs. J Vet Intern Med 2024; 38(4): 2196–203.
Berger T, Reindl M. Biomarkers in multiple sclerosis: role of antibodies. Dis Markers 2006; 22(4): 207–12.
Lichtenberg D, Pinchuk I. Oxidative stress, the term and the concept. Biochem Biophys Res Commun 2015; 461(3): 441–4.
Attig F, Spitzbarth I, Kalkuhl A, Deschl U, Puff C, Baumgärtner W, Ulrich R. Reactive oxygen species are key mediators of demyelination in canine distemper leukoencephalitis but not in theiler’s murine encephalomyelitis. Int J Mol Sci 2019; 20(13): 3217.
Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52(3–4): 591–611.
Levene H. Robust tests for equality of variances. In: Olkin I, ed. Contribu-tions to probability and statistics. Stanford: Stanford University Press, 1960: 278–292.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143(1): 29–36.
Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken: John Wiley & Sons, 2013.
An, D. J., Kim, T. Y., Song, D. S., Kang, B. K., & Park, B. K. (2008). An immunochromatography assay for rapid antemortem diagnosis of dogs suspected to have canine distemper. Journal of Virological Methods, 147(2), 244–9
Pranitha, P., Jhala, M. K., & Bhanderi, B. B. (2022). Comparison of lateral flow assay and polymerase chain reaction for diagnosis of canine distemper. VirusDisease, 33(1), 96-101.
Sarchahi, A. A., Arbabi, M., & Mohebalian, H. (2022). Detection of canine distemper virus in cerebrospinal fluid, whole blood and mucosal specimens of dogs with distemper using RT‐PCR and immunochromatographic assays. Veterinary medicine and science, 8(4), 1390–9.
Dinçel GÇ, Yavuz O, Yıldırım S. Role of glial fibrillary acidic protein (GFAP) and neurofilament (NF) expression in the pathophysiology of canine distem-per encephalomyelitis. Turk J Vet Res 2023; 7(2): 107–13.
Bavato F, Barro C, Schnider LK, Simrén J, Zetterberg H, Seifritz E, Quednow BB. Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls. Mol Psychiatry 2024; 29(8): 2543–59.
Krakowka S, McCullough BR, Koestner A, Olsen R. Myelin-specific auto-antibodies associated with central nervous system demyelination in canine distemper virus infection. Infect Immun 1973; 8(5): 819–27.
Değirmençay Ş, Çamkerten G, Çamkerten İ, Aktaş MS. An investigation of thiol/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in dogs with canine distemper. Vet Arhiv 2021; 91(1): 39–49.
Karadeniz A, Hanedan B, Cemek M, Borku MK. Relationship between canine distemper and oxidative stress in dogs. Rev Med Vet 2008; 159(1): 462–7.
Kurtdede E, Börkü MK, Gür B, Doğan Y, Sevim K, Gülendağ E. Evaluation of CBC, lipid profile, oxidative stress biomarkers, total thiol, native thiol, and disulfide levels in dogs diagnosed with parvoviral enteritis without clinical findings. Vet Sci Pract 2022; 17(3).
Şenel Y, Terzi OS, Kara E, Erel Ö, Neşelioğlu S, Ceylan E. Alterations in serum thiol-disulfide homeostasis and ischemia-modified albumin concen-trations in clinical canine parvoviral enteritis. Turk J Vet Anim Sci 2024; 48(2): 88–96.
Rubio, C. P., & Cerón, J. J. (2021). Spectrophotometric assays for evalua-tion of Reactive Oxygen Species (ROS) in serum: General concepts and appli-cations in dogs and humans. BMC Veterinary Research, 17(1), 226.
Smolek T, Vince-Kazmerova Z, Hanes J, Stevens E, Palus V, Hajek I, et al. On the utility of cerebrospinal fluid biomarkers in canine neurological disor-ders. Sci Rep 2024; 14(1): 24129.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mustafa Güven *, Nurperi Keskin, Halime Kara, Berna Gür, Erdal Kara

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.